Akebia therapeutics, inc. (AKBA)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Operating activities:
Net loss

-267,985

-279,659

-245,230

-216,692

-192,591

-143,588

-68,011

-65,098

-52,546

-73,671

-127,056

-140,230

-154,492

-135,747

-117,742

-100,909

-75,819

-60,716

-51,229

-41,103

-38,032

-37,034

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

2,331

2,245

1,920

1,512

1,139

899

835

777

681

617

544

471

399

296

183

124

109

96

101

79

60

49

0

0

0

Amortization of intangibles

36,401

36,401

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of premium/discount on investments

-

819

1,329

1,604

1,649

1,232

631

92

-359

-610

-638

-596

-541

-494

-539

-574

-567

-558

0

0

0

-

-

-

-

Non-cash interest expense

1,054

786

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash operating lease expense

-2,262

-2,229

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair value write-up of inventory sold

67,038

70,444

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Write-down of inventory

5,512

7,112

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

14,747

11,925

19,053

18,693

18,902

19,040

9,171

9,070

9,083

8,867

0

0

0

-

-

-

-

4,714

4,271

4,344

4,693

6,010

0

0

0

Deferred income taxes

-

-6,631

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of derivative liability

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Fair value of warrants issued for license

-

-

-

-

-

-

-

-

-

3,413

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

56,437

22,198

13,132

12,922

-3,251

-33,384

407

132

35,852

393

0

0

0

-

-

-

-

-

-

-

-

-

0

0

0

Inventory

21,241

29,142

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

-7,326

-10,541

-8,784

13,500

-1,836

977

2,742

-6,012

4,596

4,193

106

7,280

723

-428

2,488

1,702

142

1,001

-226

346

767

686

0

0

0

Other long-term assets

-4,244

-4,917

0

0

0

-

-

-

-

991

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable

42,588

1,372

34,469

-3,708

-17,911

13,717

3,979

-5,417

2,797

4,959

196

5,069

12,668

-274

3,175

2,670

-1,975

231

0

0

0

-

-

-

-

Accrued expense

-14,060

-27,351

-15,812

-1,191

35,583

55,482

72,926

52,068

20,375

21,974

3,852

12,794

23,244

20,703

8,639

12,386

6,514

4,646

0

0

0

-

-

-

-

Operating lease liabilities

2,427

2,531

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-28,786

-39,739

-75,494

-63,629

-63,762

-66,935

-54,209

-78,374

-6,190

-17,665

165,732

197,877

136,423

197,289

0

0

0

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

418

-164

-152

-82

314

565

1,454

2,578

2,411

0

0

0

-

-

-

-

-

-

-

-

Net cash used in operating activities

-209,101

-257,441

-239,005

-262,455

-215,093

-97,494

-40,173

-82,329

-66,961

-56,159

55,889

82,263

30,944

57,906

-60,676

-41,464

-26,626

-52,407

-38,698

-35,270

-29,822

-27,483

0

0

0

Investing activities:
Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

Purchase of equipment

-

6,655

7,265

5,043

3,238

1,606

1,226

1,516

1,491

1,622

1,220

1,879

2,980

2,662

2,686

1,545

323

414

363

285

287

229

0

0

0

Proceeds from the maturities of available for sale securities

74,664

153,110

193,788

224,157

265,630

243,269

232,221

218,683

181,838

149,998

135,093

151,620

171,552

162,376

139,505

93,985

69,630

63,901

55,142

40,630

16,670

12,585

0

0

0

Proceeds from sales of available for sale securities

-

64,721

64,721

69,723

41,711

13,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of available for sale securities

-

-

-

-

-

224,216

237,426

274,566

262,869

330,636

280,519

205,861

163,215

147,009

144,782

160,425

171,355

77,175

0

0

0

-

-

-

-

Net cash provided by investing activities

100,948

211,176

205,613

192,234

134,633

36,594

11,569

-44,401

-72,523

-177,260

-146,646

-56,120

5,357

12,705

-7,963

-67,985

-102,048

-13,688

-22,963

-48,506

-67,305

-65,352

0

0

0

Proceeds from the issuance of redeemable convertible preferred stock, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from the issuance of common stock, net of issuance costs

0

-

-

-

-

95,452

100,492

163,083

208,536

114,580

113,072

52,779

7,125

66,736

0

0

0

-

-

-

-

-

-

-

-

Proceeds from the sale of stock under employee stock purchase plan

646

383

383

453

452

482

483

445

446

353

0

0

0

-

-

-

-

220

0

0

0

-

-

-

-

Proceeds from the exercise of stock options

607

560

652

710

829

647

759

1,631

1,427

1,312

1,107

182

173

124

0

0

0

-

-

-

-

-

-

-

-

Payments on debt

-

15,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on capital lease obligations

-

-

-

-

-

19

14

8

4

5

5

17

19

20

21

10

9

7

0

0

0

-

-

-

-

Net cash provided by financing activities

160,765

88,970

-5,363

-5,204

-13,796

96,562

101,720

165,151

210,405

116,240

114,526

53,070

7,510

66,946

67,757

79,378

144,226

83,093

78,705

64,630

-1,305

104,400

0

0

0

Increase in cash, cash equivalents, and restricted cash

52,612

42,705

-38,755

-75,425

-94,256

35,662

73,116

38,421

70,921

-117,179

23,769

79,213

43,811

137,557

-882

-30,071

15,552

16,998

17,044

-19,146

-98,432

11,565

0

0

0

Non-cash financing activities
Unpaid offering costs

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unpaid initial public offering issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Unpaid follow-on offering costs

-

-

-

-

-

-

-

-

0

-

-

18

2

12

0

0

0

-

-

-

0

-

-

-

-

Assets acquired under capital lease

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12

0

0

0

-

0

0

0